Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 53Neoplasms 49Neoplasm Metastasis 44Colorectal Neoplasms 44Leukemia, Myeloid, Acute 42Breast Neoplasms 40Prostatic Neoplasms 36Multiple Myeloma 31Ovarian Neoplasms 29Recurrence 26Melanoma 24Lymphoma, Non-Hodgkin 24Squamous Cell Carcinoma of Head and Neck 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Pancreatic Neoplasms 23Triple Negative Breast Neoplasms 21Myelodysplastic Syndromes 21Endometrial Neoplasms 20Carcinoma, Renal Cell 18Stomach Neoplasms 17Small Cell Lung Carcinoma 17Lung Neoplasms 17Advanced Solid Tumors 17Carcinoma, Hepatocellular 15Brain Neoplasms 15Sarcoma 14Glioblastoma 14Esophageal Neoplasms 12Urinary Bladder Neoplasms 11Solid Tumors 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Testicular Neoplasms × 30 days × Clear all
NCT06515613 2026-06-02

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Context Therapeutics Inc.

Phase 1 Recruiting
156 enrolled
GenitourinaryGynecologic

Testicular Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡